Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  746 results for ""Antineoplastic Combined Chemotherapy Protocols adverse effects""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.

Subjects: Trastuzumab; ERBB2 protein, human; tucatinib

  • Source: Journal of Clinical Oncology, 41 (36), 5569 - 5578 (2023-12-20)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8.

Subjects: Anastrozole; Aromatase inhibitors; Breast neoplasms

  • Source: Breast, 72, 103580 (2023-12)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.

Subjects: Decitabine; Cytarabine; Daunorubicin

  • Source: The Lancet Haematology, 10 (11), e879 - e889 (2023-11)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia

Subjects: adverse events; chronic lymphocytic leukaemia; survival

  • Source: Vainer , N , Aarup , K , Andersen , M A , Wind-Hansen , L , Nielsen , T , Frederiksen , H , Enggaard , L , Poulsen , C B , Niemann , C U & Rotbain , E C 2023 , ' Real-world outcomes upon second-line

Record details

Read More Add to Saved list
×
Academic Journal

Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer

Subjects: Breast cancer; Chemotherapy; Interleukin-8

  • Source: Schauer , T , Henriksson , A , Strandberg , E , Lindman , H , Berntsen , S , Demmelmaier , I , Raastad , T , Nordin , K & Christensen , J F 2023 , ' Pre-treatment levels of inflammatory markers and

Record details

Read More Add to Saved list
×
Academic Journal

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

Subjects: info:eu-repo/classification/ddc/616; Humans; Urinary Bladder Neoplasms / drug therapy

  • Source: ISSN: 0732-183X ; Journal of clinical oncology, vol. 41, no. 33 (2023) p. 5131-5139.

Record details

Read More Add to Saved list
×
Academic Journal

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence

Subjects: info:eu-repo/classification/ddc/616; Head and neck squamous cell carcinoma; Metastatic

  • Source: ISSN: 1368-8375 ; Oral oncology, vol. 147 (2023) 106587.

Record details

Read More Add to Saved list
×
Academic Journal

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

Subjects: Gynecologic Oncology; Hematology/Oncology; Obstetrics/Gynecology

  • Source: Mirza , M R , Chase , D M , Slomovitz , B M , Depont Christensen , R , Novák , Z , Black , D , Gilbert , L , Sharma , S , Valabrega , G , Landrum , L M , Hanker , L C , Stuckey , A , Boere , I , Gold

Record details

Read More Add to Saved list
×
Academic Journal

Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX):A Randomized, Open-Label, Phase III Trial

Subjects: Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Dexamethasone

  • Source: Dimopoulos , M A , Oriol , A , Nahi , H , San-Miguel , J , Bahlis , N J , Usmani , S Z , Rabin , N , Orlowski , R Z , Suzuki , K , Plesner , T , Yoon , S-S , Ben Yehuda , D , Richardson , P G ,

Record details

Read More Add to Saved list
×
Academic Journal

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.

Subjects: Hematology/Oncology; Leukemia/Lymphoma; Treatments in Oncology

  • Source: Eichhorst , B , Niemann , C U , Kater , A P , Furstenau , M , Von Tresckow , J , Zhang , C , Robrecht , S , Gregor , M , Juliusson , G , Thornton , P , Staber , P B , Tadmor , T , Lindstrom , V , Da

Record details

Read More Add to Saved list
×
  • 1-10 of  746 results for ""Antineoplastic Combined Chemotherapy Protocols adverse effects""